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Abstract 
Comparability of population surveys across countries is key to appraising trends in 
population health. Achieving this requires deep understanding of the methods used in these 
surveys to examine the extent to which the measurements are comparable. In this paper, we 
obtained detailed protocols of eight nationally representative surveys in seven countries from 
Latin America, the United Kingdom and the United States of America 2007-2013 that differ in 
economic and inequity indicators. Data on sampling frame, sample selection procedures, 
recruitment, data collection methods, content of interview and examination modules, and 
measurement protocols were collected.  We also assessed their adherence to the WHO 
STEPwise approach to Surveillance framework for population health surveys. The surveys, 
which included half a million participants, were highly comparable on sampling methodology, 
survey questions and anthropometric measurements. Heterogeneity was found for physical 
activity questionnaires and biological samples collection. The common age range included by 
each survey was adults aged 18 to 64 years old. The methods used in these surveys were 
similar enough to enable comparative analyses of the data across the seven countries. This 
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is crucial in assessing and comparing national and subgroup population health, and to 
assisting the transfer of research and policy knowledge across countries. 
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Introduction 
Chronic non-communicable diseases (NCDs) are a growing problem worldwide,(1) affecting 
low and middle income countries as well as more affluent countries. There is increasing 
political commitment globally to improve treatment and prevention of NCDs.(2,3) However, 
data based on health service use or users ignore those not accessing healthcare, for diverse 
reasons; data from health interview surveys ignore those with undiagnosed disease - millions 
of individuals in developing countries. Administrative data fails to represent those with 
undiagnosed disease and limits the ability to design, implement and monitor timely policies 
and interventions to prevent, detect, or manage such diseases. For example, almost half the 
cases of diabetes identified by the health examination survey (through blood tests) in Mexico 
in 2006 were undiagnosed.(4) 
 
Interview-based data can also mislead. For example, self-reported weight is often 
underestimated and height overestimated(5) to a variable extent.(6,7,8,9,10,11) Self-
perception of obesity category also varies.(12,13) These inaccuracies limit the capacity to 
design, implement and monitor timely policies and interventions to prevent, detect, and 
manage NCDs and their risk factors.  
 
Health examination surveys collect self-reported data through interview or questionnaire and 
also take physical and biological measurements, such as anthropometry, blood pressure and 
blood sugar levels. These enable more accurate estimation of population prevalence and 
severity of diseases such as hypertension or diabetes, including undiagnosed 
disease.(14,15,16,17) Evidence from Mexico, the UK and the USA show that data from 
examination surveys are used by policy-makers to identify health problems and aid decision-
making(18,19,20,21); this is a legal requirement in Chile. Given the importance of 
socioeconomic, geographical and ethnic inequalities in mortality and morbidity,(22,23,24) 
health examination surveys also permit more accurate understanding of inequalities in 
disease prevalence, detection, and management, including healthcare use.(5,25) These 
surveys are significantly more expensive to run than interview surveys, although the cost of 
running one health examination survey was 0.03% of health and social care costs and 0.01% 
of societal costs for the main diseases monitored by the survey (S Morris, personal 
communication). 
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Comparisons across countries or regions of the world are increasingly used to benchmark 
services and learn from others’ experiences. For example, Brazil considers evaluations by 
three of the most established health technology assessment agencies in the world: National 
Institute for Health and Care Excellence in the UK (NICE), Canadian Agency for Drugs and 
Technologies in Health (CADTH) and Australia’s health ministry as part of their own 
assessment.(26) 
 
Such comparisons can also be used to assess the extent to which differences in disease 
prevalence between areas is amenable to changes in socioeconomic conditions and/or 
health or other policy interventions.(27) Early comparisons were hampered by using 
dissimilar data sources.(28) More useful data are obtained from studies designed at the 
outset to collect data in a uniform way. Examples include the Health, Alcohol and 
Psychosocial factors in Eastern Europe (HAPIEE) study,(29) and the World Health 
Organization (WHO) MONItoring of trends and determinants in CArdiovascular disease 
(MONICA) Project.(30) However, neither collected nationally representative data. 
 
Increasing numbers of countries are introducing nationally-representative, general population 
health examination surveys. Many are learning from other countries’ experience.(31) Funding 
co-ordinating centers allows common protocols to be developed and shared, such as the 
WHO’s Study of AGEing Populations,(32) the WHO’s STEPwise approach to risk factor 
surveillance (STEPS) program(33) or the European Union-funded European Health 
Examination Survey pilot.(34) 
Surveys set up independently may still be sufficiently comparable to allow policy-relevant 
cross-national data analyses. Comparisons of sampling, recruitment and participation across 
the more established national examination surveys in European countries demonstrated 
comparability in many aspects but differences in eligibility, definitions of response rates in 
country-specific reports, and particularly a dichotomy of location for data collection: fieldstaff 
in England and Scotland visit potential participants in their own homes, but participants in 
continental Europe are invited to attend a central examination center.(35)  
 
This paper provides descriptions of the methods used by five general population health 
examination surveys in four Latin American countries (Brazil, Chile, Colombia, and Mexico) 
and three long-established surveys – the National Health And Nutrition Examination Survey 
(NHANES) in the USA and the Health Survey for England (HSE) and Scottish Health Survey 
(SHeS) in the UK – and compares them with the WHO STEPS approach.  Four Latin 
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American countries have conducted at least two nationally-representative health examination 
surveys (Chile, Colombia and Mexico) or are conducting a second one (Brazil). By describing 
the methods they have used, this paper brings them to the attention of an English-speaking 
audience. Comparisons have been made with NHANES in the USA, both due to its ‘gold 
standard’ reputation for health examination surveys and because of being Latin America’s 
nearest neighbor.(36) The second national examination survey included as a comparator is 
the Health Survey for England.(37) This started in 1991 and is larger than NHANES, though 
with fewer measurements made. The Scottish Health Survey, started in 1995, has used 
similar methods for data collection as its counterpart in England. Like these two UK surveys, 
the Latin American surveys collect data only at participants’ home. We examine sample 
selection, recruitment of participants, data collection methods, and examination protocols 
and compare these with the WHO’s standardized protocols for STEPS.. This will enable 
policy-makers and practitioners to understand better the sources of data on the prevalence 
and severity of diagnosed and undiagnosed disease in these countries and the extent to 
which such data are comparable. This is the first paper from the Encuestas de Salud de las 
Americas y el Reino Unido (ESARU) network of health examination survey researchers from 
the Americas and the UK.  
 
<Insert Abbreviated Table 1 around here> 
 
Methods 
Surveys 
Most of the seven countries had more than one health examination survey in a series that 
changed little in methods over the last decade. We compared the most recent completed 
survey in each country, except in Colombia where two different health examination surveys 
had collected different measurements. We obtained information on the following health 
examination surveys, from published reports and through discussion with survey staff: 
Pesquisa Nacional de Saúde (PNS) 2013, Brazil(38) 
Encuesta Nacional de Salud (ENS) 2009-10, Chile(39,40) 
Encuesta Nacional de Salud (ENS), 2007, Colombia(41) 
Encuesta Nacional de la Situación Nutricional en Colombia (ENSIN), 2010, Colombia(42) 
Encuesta National de SAlud y NUTrición (ENSANUT) 2012, Mexico(43)  
Health Survey for England (HSE) 2013, England(37,44) 
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Scottish Health Survey (SHeS) 2008-2011, Scotland(45,46) 
National Health And Nutrition Examination Survey (NHANES) 2011-12, USA(36) 
 
Information was collected on sampling frame, sample selection procedures, recruitment, data 
collection methods, and content of interview and examination modules, using the WHO 
STEPS protocol as the framework.(33) The detailed protocols for biophysical measurements 
(height, weight, waist and hip circumference, blood pressure, and biological samples) were 
obtained and compared. Web Appendix 1 (available at http://aje.oxfordjournals.org/) provides 
information on where the questionnaires and protocols for these surveys can be obtained. 
 
 
Results 
Sample design, target population, participant recruitment and response rates 
Table 1 provides health-relevant information about the seven countries. Table 2 shows the 
target population and inclusion and exclusion criteria in the eight surveys. All the surveys had 
a target population of the free-living (non-institutionalized) general population. In the USA, 
military personnel were excluded. All the surveys included the WHO STEPS target age-
group of 25-64y; only ENS from Colombia had an upper age limit but the minimum age for 
eligibility varied among the surveys. In each survey, those who could not speak the 
majority/official language of that country were ineligible but no survey excluded them from 
the sampling frame. 
 
<Insert Table 2 around here> 
 
All surveys used multistage, probability sampling. The number of sampling stages and 
number of individuals selected per household varied between surveys (Table 2 and web 
table 2). In the Brazilian and Chilean surveys, only one individual was selected per 
household; in the Colombian ENS, two were selected if there were more than four eligible 
individuals in the household. In Mexico, one individual from each of four age groups plus one 
or two recent users of health services were selected, while in the USA, individuals were 
randomly selected to fill quotas by sex, age, ethnicity and income. In the Colombian ENSIN 
and the English and Scottish surveys, all adults (maximum 10) in the selected household 
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were invited to participate. All surveys used a Kish grid to select specific participants at 
random where more eligible individuals were present. 
Each survey stratified the primary sampling units at the first sampling stage, mainly 
geographical or by level of urbanization. In England, Scotland, and both Colombian surveys, 
stratification also included socio-economic indicators. Clustering of the sample (to reduce 
fieldwork costs) was used in each country except Scotland, which was clustered 
geographically within each year 2008-2011 but was not clustered over the fixed four-year 
period. No clusters were overlapping. 
Details of each stage are provided in Web Table 2, including the nature and number of the 
sampling units and the stratification variables. Each survey selected at least 100 primary 
sampling units, above the 50-100 minimum recommended by the STEPS protocols. 
Probability proportional to size sampling for the primary sampling units (where the probability 
of selection into the survey sample for each cluster is proportional to its relative size) was 
used by each survey. Deliberate oversampling was employed in some surveys to ensure 
adequate sample size for subgroup analysis, for example by region (England), urban/rurality 
(Chile), or population subgroup (Chile, Mexico, USA). In these cases, sample selection 
weights were calculated for data analysis to facilitate reconstruction of population estimates 
from sample estimates. 
No survey used replacement for dealing with non-response, conforming with the WHO 
STEPS recommendation. Each survey excluded addresses that were not occupied private 
homes; and residents in institutions; and persons not in the target population. 
Web table 3 compares recruitment methods and data collection methods in the surveys. All 
surveys included face-to-face recruitment on the doorstep; some also sent an information 
letter before the fieldworker visited. In the USA, health examinations took place in mobile 
examination centers, with doctors, nurses, and phlebotomists. In the other studies, health 
examinations were carried out by nurses in the participants’ home.  
 
 
Achieved survey size ranged from >5400 individuals interviewed in Chile to >160,000 in each 
Colombian survey. Web table 3 details the response rates to each major survey stage, where 
available: interview, height and weight measurement, blood pressure measurement, and 
taking blood samples. Generally, around 80% of households co-operated but response rates 
for biophysical measurements decreased markedly, especially for blood samples, with a high 
heterogeneity of the blood sample response rate from 33% in Scotland to 91% in Chile. 
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Research ethics approval 
For each survey, the relevant institutional or national ethics review board approved the 
survey and free and informed consent of the participants (or, for children, their legal 
guardians) was obtained. 
 
Questionnaire information collected  
Demographic data: Age and sex were universally captured. Ethnic group or indigenous 
background was collected in each country other than Chile, using the relevant categories for 
that country.  
Socio-economic data: Household income was collected in all surveys except in Colombia, 
and education level in all surveys.  
Health status: Each survey included a measure of self-rated general health. All but 
Colombia’s ENSIN survey asked about doctor-diagnosed chronic illnesses, including 
diabetes, hypertension, heart attack, angina and stroke. Some, but differing, information on 
medication use was collected in each survey except ENSIN in Colombia. 
Lifestyle factors were considered by all studies, including directly comparable smoking status 
(current, ex- or never smokers) for all except ENSIN. Information about alcohol intake was 
measured by all surveys but ENSIN, although with a variety of questions, including drinking 
frequency, heaviest drinking day in the last week or month, and total weekly or monthly 
consumption. Chile and the USA used the Global Physical Activity Questionnaire, as 
recommended by STEPS, while Colombia ENSIN, Mexico and England used the 
International Physical Activity Questionnaire. Diet (most commonly fruit and vegetable intake) 
was recorded across all surveys but the information was not directly comparable as some 
surveys used short modules (e.g. food frequency questionnaires) and others used 24-hour 
recall.  
Web Table 4  lists in more detail the items proposed by STEPS for core and extended 
modules of questions and what each country’s most recent health examination survey 
collected in relation to these.  
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Health examination measurements 
The major examination measurements were more comparable across the surveys than 
interview measures (Web table 5 compares the surveys’ protocols with those specified by 
STEPS; this is summarized in Table 3).  
 
 
Height and weight were measured and body mass index calculated in all surveys. In all 
countries, shoes were removed, and the head was positioned in the Frankfort plane for 
height. In Chile, a straight wall (without skirting board) and set-square were used to make the 
height measurement but all other countries used a stadiometer and heavy clothing was taken 
off for weight.  
Waist circumference was measured in all surveys except Colombia ENS, with the same 
protocol in each country (horizontal measurement midway between lowest rib and iliac crest). 
Chile included an additional measurement over the iliac crest to assess inter-observer 
variability for waist measurement quality control.  
Hip measurement (at the widest part) was also taken in Brazil, Mexico, England and 
Scotland. The Brazil, England and Scotland protocols mandated two readings unless they 
were >3cm different. 
Blood pressure was measured in all countries but not all surveys (not measured in ENSIN in 
Colombia). Measurements were taken by a nurse in the participants’ home except in the 
USA, where a doctor carried out the measurement in a mobile examination center. Electronic 
sphygmomanometers were used in Brazil, Chile, Colombia, England and Scotland; mercury 
sphygmomanometer in the USA; and both in Mexico, where a validation exercise was 
conducted to compare the measurements. Brazil, Mexico, England and Scotland used the 
same device; Chile and Colombia used different devices from the same manufacturer. Most 
countries used a range of cuff sizes but Colombia used only a standard adult cuff. In all 
countries, participants were seated for 5 minutes before the measurement was taken. Other 
restrictions varied (Web table 5). Colombia had the most stringent exclusion criteria. One 
measurement was taken in Colombia (ENS); two in Mexico, and three (STEPS protocol) in 
the other countries. These measurements were restricted to 08.00-11.00 in Chile (mean 
09.00), but not in other surveys. 
In Brazil, Mexico, and Colombia ENS, only a random sub-sample of participants were eligible 
for biological sampling. Venous blood samples were taken in each survey (by nurses or 
phlebotomists) except in Colombia, where microbiologists collected capillary samples for 
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ENS; no blood samples for cholesterol or glycemia were collected in ENSIN. All countries 
analyzed the samples for markers of diabetes (glycated hemoglobin and/or fasting glucose) 
and total- and HDL-cholesterol. Blood samples were taken fasting in Colombia ENS, Chile, 
Mexico and the USA, whilst they were non-fasting and at any time of the day in Brazil, 
England, and Scotland. Other analyses varied by survey and/or survey year. 
Urine samples were taken in Brazil, Chile, England, Scotland and the USA. Sodium was 
measured in all but the USA, plus creatinine to standardize the sample volume. Less 
commonly analyzed were albumin, potassium, various minerals, or markers of sexually 
transmitted diseases. 
Other biophysical measurements were taken less commonly. Additional anthropometric 
measures were taken in Chile, England, Scotland, and the USA. Lung function was 
measured through spirometry (England, Scotland and the USA). Saliva samples were taken 
in England and Scotland, for cotinine (a marker of tobacco exposure). Oral and vaginal 
swabs were taken in the USA (for Human Papilloma virus).  
 
<Insert Table 3 around here> 
 
 
Linkage to other data 
Participants in England, Scotland, and the USA were asked for permission to link their survey 
data to mortality data. In England and Scotland, permission was also sought for linkage to 
national cancer registry and hospital admissions data. In Chile and Brazil, linkage of survey 
data to mortality data is requested from national authorities, not participants. 
 
 
Discussion 
We used the WHO STEPwise approach to risk factor surveillance program to conduct a 
systematic assessment of the design methods of eight population surveys in seven 
countries. Overall, survey questionnaires and anthropometric measurements were highly 
comparable, with minor differences across surveys. Less overlap was found when comparing 
measurements that use biological samples.  
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Sample selection: key similarities and differences 
All the assessed surveys were nationally representative of the non-institutionalized general 
population of speakers of that country’s main language. Each survey had a multistage, 
probability sampling design. Oversampling was undertaken in three surveys to enable 
subgroup analysis but each provided sample selection weights to ensure national analyses 
would be representative. The number of individuals selected in each household varied 
across surveys but the details and rationale were well described for each. The common age 
range for all surveys was 18-64 years, exceeding the WHO STEPS minimum (25-64). Face-
to-face recruitment was used in all surveys, and biophysical measurements were carried out 
by health professionals in the participants’ own home, except in the USA where the 
measurements were conducted in mobile examination centers. This contrasts with a 
comparison of methods of nationally-representative health examination surveys in Europe, 
where participants were invited to central examination centers in five of the seven countries 
studied.(Error! Bookmark not defined.) 
Response rates varied considerably, particularly for blood samples, but were consistently 
higher in Latin America than in most European health examination surveys, where survey 
response rates have been falling.(Error! Bookmark not defined.) Some of the factors 
affecting response rates to health examination surveys have been discussed 
elsewhere.(Error! Bookmark not defined.) There is reasonable evidence that pursuing 
higher response rates tends to recruit more people like those who have already taken part; 
adjustment for non-response reduces bias more than additional expensive attempts to 
increase recruitment beyond what can be achieved with a usual degree of effort.(47) 
 
Measurement protocols: key similarities and differences 
Country-specific protocols for survey questionnaires and anthropometric measurements 
showed good agreement with the STEPS protocol. Comparable equipment and protocols 
were used for waist circumference in all surveys; only Chile differed from STEPS for height 
and weight. In Chile, measurement variability was 60% less using a wall and set-square than 
a stadiometer, and reduced costs (P Margozzini, personal communication). 
Measurement of blood pressure differed in fine detail but the protocols, exclusions, and 
ranges of cuff size used in most surveys were similar enough to enable cross-country data 
comparison with reasonable confidence. In Chile, blood pressure was measured in the left, 
not right, arm, so systolic blood pressure in Chile may be underestimated by an average of 
1.8mmHg, and diastolic blood pressure overestimated minimally.(48) Taking three 
measurements (not done in Colombia or Mexico) is important: mean systolic pressure and 
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hypertension prevalence are lower (by 0.5mmHg and 1%, respectively) after incorporating a 
third measurement.(49) 
In the USA and Mexico, BP was measured using a mercury sphygmomanometer; in the 
other countries, an electronic device was used. Although three different machines were used, 
four countries used the same model, the Omron HEM-907, and all devices were from the 
same manufacturer. Validation of the Omron HEM-907 following an international protocol 
found mean(SD) systolic blood pressure 0.1(5.1)mmHg higher and diastolic 1.9(4.2)mmHg 
lower than mercury sphygmomanometer readings in older people.(50) A one-third sub-
sample in Mexico had measurements taken by both the electronic device and a mercury 
sphygmomanometer. They found the electronic devices recorded slightly higher systolic and 
slightly lower diastolic blood pressures, but hypertension prevalence was not affected 
(SBarquera, personal communication). Another study found no difference in systolic, and 
lower diastolic, pressures with non-clinical staff using electronic devices compared with 
healthcare staff using mercury devices.(51) We recommend that any future study comparing 
blood pressure and hypertension data across countries could use that internal comparability 
data to determine what adjustments, if any, are required to ensure comparability of data 
measured with mercury or electronic sphygmomanometers. 
More heterogeneity was seen when comparing the collection of biological samples. Venous 
blood samples were taken from all surveys except Colombia. Capillary samples were 
collected in Colombia ENS. Blood samples were taken fasting in the surveys in Chile, 
Mexico, Colombia and the USA but non-fasting and at any time of day in Brazil, England, and 
Scotland; affecting comparability of blood lipids and glucose but not of glycated hemoglobin 
that reflects long-term glycemia. Additional biophysical measurements varied across surveys. 
For detecting undiagnosed diabetes, fasting capillary glucose would be directly comparable 
with each other but not with the fasting venous blood glucose samples. However, venous 
blood samples can underestimate glucose levels unless the correct anticoagulant is 
supplemented with an inhibitor to prevent red blood cells metabolizing the glucose while in 
transit to the laboratory (not a problem in the USA, where blood samples were processed 
immediately). This is also not a problem with glycated hemoglobin (HbA1C) measurement, 
which has the additional advantages of not requiring a fasting sample because of measuring 
longer term hyperglycemia. However, it is much more expensive to measure. Hence, fasting 
plasma glucose has been standard in large population surveys in low and middle income 
countries because of budget constraints. Now that measurement of glycated hemoglobin has 
been standardized internationally, there is an agreed definition of diabetes using glycated 
hemoglobin.(52) Thus the prevalence of undiagnosed diabetes can be compared across the 
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different studies with reasonable confidence, using the relevant definitions, although the 
extent of poor control of diagnosed diabetes cannot. 
The focus of our study was primarily the examination elements of the surveys. However, 
comparability of self-reported cardiovascular risk factors is also important. Regarding 
physical activity instruments, GPAQ was used in Chile and the USA; IPAQ was used in 
Colombia and Scotland. GPAQ and IPAQ have been compared in multiple countries and 
found to have moderately strong concurrent validity,(53) although activity is overestimated 
when compared with accelerometry.(54) Use of different instruments would generally enable 
identification of inactive individuals, although categorization of other participants into more or 
less active may be inconsistent.(55) The travel module of both GPAQ and IPAQ would allow 
comparison of data in Chile, Colombia, Scotland and USA.(56) 
 
Recommendations for future population surveys 
Despite the expense, a number of countries now have national examination surveys of 
health. Pan-European collaborations have demonstrated that the desire to conduct 
nationally-representative health examination surveys exists in most countries, and that 
despite the constraints of limited resources, the number of countries who are developing, 
piloting, and conducting full-size examination surveys is increasing (e.g. Portugal, 
Luxembourg, Serbia).(57) Korea has run an annual survey similar to NHANES since 1998, 
where participants attend a mobile examination center.(58) There are also national health 
examination surveys in Canada (since 2007-09),(59) Australia,(60) and New Zealand.(61) 
The last of these started as a health interview survey. Since 2002/03, elements of an 
examination survey have been added gradually, following the WHO STEPS approach of 
measuring height and weight, then adding blood pressure, and most recently taking 
biological samples.(61) Other countries, such as the Philippines, have national nutrition 
surveys which include biochemical and anthropometry measurements but not blood pressure 
and other physical measurements. The lack of an up-to-date global register makes it difficult 
to identify all such studies; the WHO database of STEPS surveys addresses this issue for 
low and middle income countries.(62) 
 
Comparable population surveys are essential to keep measurements consistent over time 
and to evaluate the health status of the population and specific population subgroups. 
Further, they allow cross-country comparison of data, with the potential advantage of 
enabling knowledge transfer on effective programs and policy decisions across 
countries.(63) By building comparable data sources, researchers and policy-makers can: 
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learn from other countries’ experiences on what works best; set common benchmarks on 
preventing chronic conditions and risk factors; determine rates of undiagnosed chronic 
conditions; and perform comparative risk assessment studies.(64) Given the aging 
population worldwide, including in low and middle income countries, and the increase in 
incidence of NCDs with age, we recommend that the STEPS recommended minimum upper 
age limit increases, where NCDs and their risk factors are the focus. Collecting more socio-
economic information will also enable assessment of within-country inequalities, important for 
realization of post-2015 sustainable development goals.(65) 
 
STEPS is an outstanding tool to standardize population-level health examination surveys 
across countries. Yet, our results indicate that it is imperative to improve the guidance on 
chronic disease surveillance and standardization of collecting data on risk factors (both for 
well-recognized problems, such as tobacco use and alcohol consumption, and emerging 
problems, such as sugar-sweetened beverages), and to improve indicators for effective 
coverage. This will also help to study changes in the food systems (nutrition transition) 
associated with chronic diseases. These goals can be accomplished by building capacities 
through international networks,(66) by enhancing a commitment to standardization of 
surveys and by facilitating funding for collective field work technology investment and 
sharing. Where we have demonstrated sufficient comparability in data, the ESARU 
consortium intends to compare prevalence of risk factors and NCDs across countries and 
time, to enhance understanding and inform policy-making. 
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Table 1. Health-relevant characteristics of seven countries in the Americas and the UK a 
Process 
Area 
(km
2
) 
Popn. 
aged 18+  
Gini 
coefficient 
(2012)  
Income 
level  
GNI per 
capita 
b
 
Popn. 
living on  
<$1.25 a 
day PPP 
(%)
 
 
Popn. living 
on  <$4 a day 
PPP (%)
  
 
Popn. living 
in urban 
areas, 2014 
(%) 
Life expectancy at birth 
(y) 
Dying 
aged 30-
70y from 
main four 
NCDs  
NCDs as 
% of all 
deaths 
Healthcare 
coverage 
c
 
Male Female 
Brazil 
8 538 
000 
135m  0.49 
Upper 
middle 
11 760 3.8%  23.8%  84.60% 71.3 78.6 19% 74% 100% 
Chile 
756 
000 
13.6m 0.51 High 14 900 0.8%  9.9%  89.20% 77.1 82.7 12% 84% 97% 
Colombia 
1 142 
000 
32.7m 0.54 
Upper 
middle 
7 780 5.6%  32.8%  75.30% 72.3 78.9) 12% 71% 94% 
Mexico 
1 944 
000 
79.5m 0.48 
Upper 
middle 
9 980 1.0%  23.7%  78.10% 71.7 77.4 16% 77% 87%  
England 
130 
427 
42.7m 0.36 
d
 High 42 690 
d
 - - 79.6% 
d
 78.9 82.7 12% 
d
 89% 
d
 100% 
Scotland 78 772 4.3m   High   - -   77.1 81.1     100% 
USA 
9 147 
000 
245m 0.41  High 55 200 - - 82.40% 76.4 81.2 14% 88% 85% 
 
GNI: gross national income); NCD: non-communicable disease; popn: population; PPP: purchasing power parity. 
aPlease see the web materials for years of population estimates. 
b Current US$, Atlas method, 2014 
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c Total coverage includes public, social security, private, and other systems.  
d Figure relates to the UK  
References:  World Bank. Country and economy factsheets. data.worldbank.org/country/.  Accessed September 22 2016. 
Portal da Saúde, Ministério da Saúde do Brasil. Brasília, Brasil. http://portalsaude.saude.gov.br/index.php/cidadao/entenda-o-sush. Accessed July 26, 2016. 
OECD. Coverage for healthcare (chapter), Society at a glance 2014. Paris, France: OECD Publishing; 2014. www.oecd-ilibrary.org/social-issues-migration-
health/society-at-a-glance-2014/coverage-for-health-care_soc_glance-2014-26-en; Accessed September 20 2016. 
Colombia Health Observatory (Así Vamos En Salud). Atención Primaria de Salud: avances y retos en Colombia). [Annual Report 2014: Progress and Challenges 
of Primary Health Care]. Bogotá: Colombia Health Observatory, 2014. http://www.fsfb.org.co/sites/default/files/Tendencias%20de%20la%20salud%20-
%20informe%20anual%202014.pdf Accessed October 3, 2016. 
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Table 2. The target population in eight national health examination surveys in the Americas and the UK 
 
Process Survey year Age range 
No. of 
stages 
Sampling of individuals Excluded from sample  Other exclusion criteria 
WHO 
STEPS 
standard 
N/A 25-64y n/a No of individuals selected n/a n/a 
Brazil PNS 2013 18+ 3 
One resident aged 18+ randomly 
selected among eligible residents 
Age <18y 
Uninhabited private household, non-
contact and refusal 
Chile ENS 2009/2010 15+ 4 
One resident aged 15+ randomly 
selected among eligible residents 
of selected households; Double 
probability for aged 65+.  
Age <15y 
Pregnant women; People with violent 
behavior; do not speak Spanish 
Colombia 
ENSIN 
2010 0-64y 4 
All individuals of interest in the 
household 
Age >65y 
 Only for anthropometric measurements: 
Women who had given birth in the 3 
months preceding the survey 
Colombia 
ENS 
2007 0-69y 4 
Aged <18: all individuals of interest 
in the household. Aged 18-69: 1 
randomly selected if <4 individuals 
aged 18-69 at the household; 2 
randomly selected if 4+  residents 
aged 18-69 
Age >69y 
Absence at time of the interview due to 
work or study 
Mexico 
ENSANUT
 
 
2012 All ages 4 
If possible, 1 individual from each 
of: children <5y;  children 5-9y; 
adolescents;  adults; and 1 or 2 
health services users 
If uninhabited private household Absence at time of the interview 
England 
HSE 
a
 
2013 All ages 3 
All adults (max 10) in selected 
address 
Business or institutions
b
, vacant 
buildings, demolished buildings, 
building still being built. 
Lack of mental capacity to give informed 
consent; do not speak English 
Scotland 
SHeS 
a
 
2008-2011 All ages 3 
All adults (max 10) in selected 
address 
Business or institutions
b
, vacant 
buildings, demolished buildings, 
building still being built. 
Lack of mental capacity to give informed 
consent; do not speak English 
USA 
NHANES
 a
 
2011/12 All ages 4 
A subsample of individuals is 
selected based on sex, age, race 
and Hispanic origin, and income 
Deadwood Dus; Institutionalised 
individual military personnel and 
citizens living outside the USA. 
Failure to provide written consent 
treated as a refusal to participate 
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ENS: Encuesta Nacional de Salud; ENSANUT: Encuesta Nacional de Salud y Nutrición; ENSIN: Encuesta Nacional de Situación Nutricional; HSE: Health Survey for England; 
NHANES: National Health And Nutrition Examination Survey; PNS: Pesquisa Nacional de Saúde; SHeS: Scottish Health Survey. 
a
 These surveys have been run on many occasions. The methods have changed little. Results in this table are for the most recent year, as an example. 
b
 Residents living in institutions (e.g. prisons, residential or nursing care, student halls of residence) were excluded, for practical reasons. 
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Table 3. Summary of comparison of national surveys in the Americas and the UK with WHO STEPS examination protocols 
 
Country Core WHO STEPS measurements taken according to protocol a 
Height Weight Waist Blood pressure Fasting blood 
glucose 
Total cholesterol 
Brazil yes yes yes yes Glycated 
hemoglobin 
yes 
Chile Differs yes yes Used left arm yes yes 
Colombia (ENSIN) yes yes yes Not done No blood sample No blood sample 
Colombia (ENS) yes yes Not done yes Capillary blood yes 
Mexico yes yes yes <3 measurements yes yes 
England yes yes yes yes Glycated 
hemoglobin 
yes 
Scotland yes yes yes yes Glycated 
hemoglobin 
yes 
USA yes yes yes yes yes yes 
ENS: Encuesta Nacional de Salud; ENSIN: Encuesta Nacional de Situación Nutricional. 
a
 yes indicates the WHO STEPS protocol was followed 
